Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Contingent Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹3.00 Cr₹0.40 Cr₹15 Cr₹8.00 Cr₹1.20 Cr

What is the latest Contingent Liabilities ratio of NATCO PHARMA ?

The latest Contingent Liabilities ratio of NATCO PHARMA is ₹3.00 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹3.00 Cr
Mar2024₹0.40 Cr
Mar2023₹15 Cr
Mar2022₹8.00 Cr
Mar2021₹1.20 Cr

How is Contingent Liabilities of NATCO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹3.00 Cr
650.00
Mar2024 ₹0.40 Cr
-97.26
Mar2023 ₹15 Cr
82.50
Mar2022 ₹8.00 Cr
566.67
Mar2021 ₹1.20 Cr -

Compare Contingent Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,180.8 Cr 1.7% -23.9% 1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.7%

-23.9%

1.4%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses